Literature DB >> 31051168

High-Temperature Requirement A1 Protease as a Rate-Limiting Factor in the Development of Osteoarthritis.

Peter H Chen1, Tian Tang2, Chenlu Liu2, Beiyu Wang3, Michelle Mian1, Chio Oka4, Maria Baquerizo1, Yefu Li5, Lin Xu6.   

Abstract

Preserving the mature articular cartilage of joints is a critical focus in the prevention and treatment of osteoarthritis. We determined whether the genetic inactivation of high-temperature requirement A1 (HtrA1) can significantly attenuate the degradation of articular or condylar cartilage. Two types of mouse models of osteoarthritis were used, a spontaneous mutant mouse model [type XI collagen-haploinsufficient (Col11a1+/-) mice] and two post-traumatic mouse models [destabilization of the medial meniscus (DMM) on the knee and a partial discectomy (PDE) on the temporomandibular joint]. Three different groups of mice were generated: i) HtrA1 was genetically deleted from Col11a1+/- mice (HtrA1-/-;Col11a1+/-), ii) HtrA1-deficient mice (HtrA1-/-) were subjected to DMM, and iii) HtrA1-/- mice were subjected to PDE. Knee and temporomandibular joints from the mice were characterized for evidence of cartilage degeneration. The degradation of articular or condylar cartilage was significantly delayed in HtrA1-/-;Col11a1+/- mice and HtrA1-/- mice after DMM or PDE. The amount of collagen type VI was significantly higher in the articular cartilage in HtrA1-/-;Col11a1+/- mice, compared with that in Col11a1+/- mice. The genetic removal of HtrA1 may delay the degradation of articular or condylar cartilage in mice.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31051168     DOI: 10.1016/j.ajpath.2019.03.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

1.  Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study.

Authors:  Christelle Sanchez; Jérémie Zappia; Cécile Lambert; Jacques Foguenne; Yvan Dierckxsens; Jean-Emile Dubuc; Jean-Pierre Delcour; André Gothot; Yves Henrotin
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

2.  Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degeneration.

Authors:  Stefan Gerhardy; Mark Ultsch; Wanjian Tang; Evan Green; Jeffrey K Holden; Wei Li; Alberto Estevez; Chris Arthur; Irene Tom; Alexis Rohou; Daniel Kirchhofer
Journal:  Nat Commun       Date:  2022-09-05       Impact factor: 17.694

3.  Placental HTRA1 cleaves α1-antitrypsin to generate a NET-inhibitory peptide.

Authors:  Robert A Campbell; Heather D Campbell; J Samuel Bircher; Claudia Valeria de Araujo; Frederik Denorme; Jacob L Crandell; John L Rustad; Josh Monts; Mark J Cody; Yasuhiro Kosaka; Christian C Yost
Journal:  Blood       Date:  2021-09-16       Impact factor: 25.476

Review 4.  Mechanotransduction pathways in the regulation of cartilage chondrocyte homoeostasis.

Authors:  Zhenxing Zhao; Yifei Li; Mengjiao Wang; Sen Zhao; Zhihe Zhao; Jie Fang
Journal:  J Cell Mol Med       Date:  2020-04-01       Impact factor: 5.310

Review 5.  Molecular structure and the role of high-temperature requirement protein 1 in skeletal disorders and cancers.

Authors:  Yihe Li; Jinbo Yuan; Emel Rothzerg; Xinghuo Wu; Huazi Xu; Sipin Zhu; Jiake Xu
Journal:  Cell Prolif       Date:  2019-12-22       Impact factor: 6.831

6.  Chromosome 10q26-driven age-related macular degeneration is associated with reduced levels of HTRA1 in human retinal pigment epithelium.

Authors:  Brandi L Williams; Nathan A Seager; Jamie D Gardiner; Chris M Pappas; Monica C Cronin; Cristina Amat di San Filippo; Robert A Anstadt; Jin Liu; Marc A Toso; Lisa Nichols; Timothy J Parnell; Jacqueline R Eve; Paul L Bartel; Moussa A Zouache; Burt T Richards; Gregory S Hageman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.